Stuttgart - Delayed Quote EUR
Intellia Therapeutics Inc (38I.SG)
8.01
+1.11
+(16.05%)
At close: May 2 at 9:26:28 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
57,877
57,877
36,275
52,121
33,053
Operating Expense
592,140
592,140
551,566
510,285
300,903
Operating Income
-534,263
-534,263
-515,291
-458,164
-267,850
Net Non Operating Interest Income Expense
47,807
47,807
49,832
8,542
1,283
Other Income Expense
-32,565
-32,565
-15,733
-24,564
-1,325
Pretax Income
-519,021
-519,021
-481,192
-474,186
-267,892
Net Income Common Stockholders
-519,021
-519,021
-481,192
-474,186
-267,892
Diluted NI Available to Com Stockholders
-519,021
-519,021
-481,192
-474,186
-267,892
Basic EPS
-5.45
-5.25
-5.42
-6.16
-3.78
Diluted EPS
-5.45
-5.25
-5.42
-6.16
-3.78
Basic Average Shares
95,998.50
98,849
88,770
76,972
70,894
Diluted Average Shares
95,998.50
98,849
88,770
76,972
70,894
Total Operating Income as Reported
-534,263
-534,263
-515,291
-458,164
-267,850
Total Expenses
592,140
592,140
551,566
510,285
300,903
Net Income from Continuing & Discontinued Operation
-519,021
-519,021
-481,192
-474,186
-267,892
Normalized Income
-486,456
-486,456
-481,092
-460,701
-267,892
Interest Income
47,807
47,807
49,832
8,542
1,283
Net Interest Income
47,807
47,807
49,832
8,542
1,283
EBIT
-534,263
-534,263
-515,291
-458,164
-267,850
EBITDA
-523,978
-523,978
-506,315
-450,592
-260,959
Reconciled Depreciation
10,285
10,285
8,976
7,572
6,891
Net Income from Continuing Operation Net Minority Interest
-519,021
-519,021
-481,192
-474,186
-267,892
Total Unusual Items Excluding Goodwill
-32,565
-32,565
-100
-13,485
--
Total Unusual Items
-32,565
-32,565
-100
-13,485
--
Normalized EBITDA
-491,413
-491,413
-506,215
-437,107
-260,959
12/31/2021 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VLA.VI Valneva SE
2.9320
+4.86%
BT3.BE Lineage Cell Therapeutics Inc
0.4320
+7.46%
HTD.MU Corcept Therapeutics Inc
63.62
0.00%
328.SG MeiraGTx Holdings PLC
6.45
+4.03%
25I.SG ImmuPharma PLC
0.0325
-1.52%
8QQ.HM AbCellera Biologics Inc
2.1850
-1.93%
HQ1.MU Oruka Therapeutics Inc. R
9.10
0.00%
CLDWW Calidi Biotherapeutics, Inc.
0.0055
-15.38%
PI3.DU Gubra AS
54.00
+9.27%
2I3.F Champions Oncology, Inc.
5.15
-19.53%